Such a study, performed by spectroscopic and nanoscopic techniques, has demonstrated the formation of a complex between the DNA binding domain (DBD) of p53 and miR-21-3p, and suggested possible molecular regions involved in the interaction; with this providing clues about new targets for novel drugs in cancer therapy. Here, TP53 is linked to cancer.